Finance

vodafone idea: What clearing vendor dues via equity means for firms

ET Intelligence Group: In a rare move by a listed company, Vodafone Idea's board in its meeting on Thursday approved the preferential allotment...

Ah parallel fund IV and affiliates execute $8.01 million in Samsara Inc. stock sales By Investing.com

In a recent move, AH Parallel Fund IV, L.P. and its affiliated funds have executed a series of transactions involving the shares of...

Donald Trump aims to entice CEOs with lucrative tax cuts while Biden wants to win them over by vowing to maintain stability

Former President Donald Trump told an influential group of CEOs that he wants to further cut the corporate tax rate he lowered while...

flipkart ipo: Flipkart’s path to profitability will decide IPO timing, says Walmart CFO

Mumbai: Walmart global chief financial officer John David Rainey said Flipkart's profitability path will influence the timing of its initial public offering (IPO)...

Monster Beverage’s vice chairman and co-CEO sells shares worth $19.79 million By Investing.com

Monster Beverage Corp's (NASDAQ:MNST) Vice Chairman and Co-CEO, Hilton H. Schlosberg, has recently sold a significant portion of his company shares....

A 58-year-old Canadian man stole trade secrets from Tesla and tried to sell them on YouTube, authorities say

A Canadian national who lives in China pleaded guilty on Thursday to conspiring to sell secrets he stole from Tesla to market battery...

Gain Therapeutics Announces Pricing of $11.0 Million Public Offering By Investing.com

BETHESDA, Md., June 13, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Gain or the Company) (Nasdaq: GANX) today announced the pricing of an...

eXp World Holdings CEO sells over $287k in company stock By Investing.com

eXp World Holdings, Inc. (NASDAQ:) CEO and Chairman of the Board, Glenn Darrel Sanford, has recently sold a significant amount of...

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants By Investing.com

NOVATO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:), a biopharmaceutical company focused on the development and...

Latest articles

spot_imgspot_img